Found: 3
Select item for more details and to access through your institution.
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats.
- Published in:
- Journal of Neuroscience Research, 2020, v. 98, n. 10, p. 1933, doi. 10.1002/jnr.24679
- By:
- Publication type:
- Article
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 overexpression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 282, doi. 10.1186/s13023-014-0201-x
- By:
- Publication type:
- Article
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article